Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related VRA
Benzinga's Volume Movers
Vera Bradley Beats Q3 EPS, Misses On Revenue
Related CRL
ICON Is Now A Strong Buy: Should It Be In Your Portfolio?
Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE

Analysts at Jefferies upgraded Vera Bradley (NASDAQ: VRA) from “hold” to “buy.” Vera Bradley's shares closed at $24.14 yesterday. Vera Bradley's trailing-twelve-month revenue is $513.10 million.

Analysts at Wells Fargo upgraded Charles River Laboratories International (NYSE: CRL) from “market perform” to “outperform.” Charles River Laboratories' stock closed at $35.65 yesterday. Charles River Laboratories' PEG ratio is 1.39.

Analysts at Keefe Bruyette upgraded M&T Bank (NYSE: MTB) from “market perform” to “outperform.” M&T Bank's shares closed at $98.11 yesterday. M&T Bank's trailing-twelve-month operating margin is 39.00%.

Analysts at Goldman Sachs upgraded Avago Technologies (NASDAQ: AVGO) from “neutral” to “buy.” Avago's shares closed at $34.57 yesterday. Avago had $1.08 billion in total cash for the latest quarter.

Latest Ratings for VRA

DateFirmActionFromTo
Sep 2014WunderlichInitiates Coverage onBuy
Sep 2014BairdUpgradesNeutralOutperform
Sep 2014Standpoint ResearchReiterates

View More Analyst Ratings for VRA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CRL + AVGO)

Around the Web, We're Loving...

Get Benzinga's Newsletters